Rocket Lab Corp. (RKLB)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-10-29
$59.10+0.85%
Close 2026-10-29 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-10-29
Research Workspace
Put RKLB beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 53% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 19%, softest on free-cash-flow margins.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 66% in its worst 12-month stretch.
View RiskRKLB’s case rests on scaling space services through backlog conversion, Iridium, and Neutron. Revenue grew 62% year over year in Q2 FY2026, though GAAP earnings missed consensus by 14.3%. Its sales multiple is 48× versus a 3× peer median, despite expectations looking modest versus our view. Neutron’s first launch moved to 2027 after a carbon-composite tank defect. Our model puts the next-quarter miss probability near 18%. Peer multiples imply a price about 41% above where it trades; our read remains intact, though provisional.
Trailing returns as of 2026-10-29. RKLB is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering RKLB (as of Oct 2026).
Based on 9 Wall Street analysts offering 12-month price targets for RKLB in the last 4 months.
Continue this research
Compare RKLB with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| RKLB Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put RKLB next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Another reported Neutron delay threatens development timing, though the headline provides no details on scope or cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $59.10
The last 12 months of price, then the range of analyst 12-month targets from today’s $59.10.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Another Neutron delay threatens a key development objective and increases execution risk.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Neutron delay threatens launch timing, though the article maintains a bullish thesis.
Threatens: Develop and launch Neutron medium-lift reusable rocket
A further Neutron delay pushes back a key product milestone.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Delay of Neutron rocket impacts growth and product development.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Delayed first Neutron launch weakens confidence in execution timing.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Missing the Neutron catalyst pressures valuation and product execution expectations.
Advances: Complete acquisition of Iridium Communications
Potential EBITDA growth from Iridium acquisition supports growth objectives.
